DUBLIN--(BUSINESS WIRE)--The "Viral Vector and Plasmid DNA Manufacturing Market by Product and Application - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.
The global viral vectors and plasmid DNA manufacturing market was valued at $261 million in 2016, and is estimated to reach at $1,090 million by 2023, registering a CAGR of 22.6% from 2017 to 2023.
The manufacturing of viral vectors and plasmid DNA is based on a unique concept that states, two people infected with the same disease do not have same physical response toward the disease. However, it depends on the surrounding environment and influence of genes and symptoms of a patient.
The global viral vectors and plasmid DNA manufacturing market is expected be driven by increase in global incidence of cancer and rise in aging population susceptible to disease. Moreover, government initiatives & grants and surge in investment by private companies on R&D related to viral vectors and plasmid DNA manufacturing are expected to boost the market growth.
The global viral vectors and plasmid DNA manufacturing market is segmented based on product, application, and geography. Based on product, it is divided into plasmid DNA, viral vectors, and non-viral vectors. Based on application, it is classified into cancer, inherited disorders, viral infections, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
- Kaneka Eurogentec S.A.
- Brammer Bio
- Cell and Gene Therapy Catapult
- FUJIFILM Diosynth Biotechnologies
- Spark Therapeutics
- Cobra Biologics
- 4D Molecular Therapeutics
- Renova Therapeutics
- Shenzhen SiBiono GeneTech Co., Ltd.
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Viral Vector and Plasmid Dna Manufacturing Market, by Product
5 Viral Vectors and Plasmid Dna Manufacturing Market, by Application
6 Viral Vectors and Plasmid Dna Manufacturing Market, by Geography
7 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/btzjsl/global_viral?w=4